VERV(Delisted)
Verve Therapeutics·NASDAQ
--
--(--)
VERV fundamentals
During Q1 2025, Verve Therapeutics (VERV) reported revenue of 32.98M, a YoY change of 479.03%. Net income was -31.03M, a YoY change of 36.32%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 929.00K -- | 1.01M -- | 1.40M -- | 2.09M -- | 3.12M +235.52% | 5.14M +408.30% | 5.70M +305.63% | 6.69M +219.73% | 6.87M +120.24% | 13.08M +154.28% | 32.98M +479.03% | 59.61M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 929.00K -- | 1.01M -- | 1.40M -- | 2.09M -- | 3.12M +235.52% | 5.14M +408.30% | 5.70M +305.63% | 6.69M +219.73% | 6.87M +120.24% | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 929.00K -- | -929.00K -- | 1.40M -- | 2.09M -- | 3.12M +235.52% | -6.61M -611.95% | 5.70M +305.63% | 6.69M +219.73% | 6.87M +120.24% | -- -- | -- -- | -- -- |
Operating Expenses | 7.37M -- | 6.69M -- | 8.97M -- | 17.60M -- | 14.06M +90.81% | 16.96M +153.72% | 23.50M +161.95% | 32.54M +84.89% | 31.93M +127.05% | 42.19M +148.71% | 44.79M +90.58% | 48.72M +49.73% | 59.66M +86.88% | 60.68M +43.81% | 55.45M +23.80% | 59.09M +21.28% | 62.54M +4.82% | 65.53M +8.00% | 63.77M +15.01% | -- -- | -- -- | -- -- |
Selling, General and Administrative Expenses | 846.00K -- | 1.03M -- | 1.35M -- | 2.02M -- | 2.72M +221.04% | 3.54M +243.12% | 6.01M +343.65% | 6.60M +226.14% | 7.43M +173.75% | 9.07M +156.06% | 9.59M +59.68% | 11.44M +73.28% | 12.55M +68.84% | 13.42M +47.97% | 11.69M +21.83% | 12.28M +7.37% | 14.16M +12.83% | 14.55M +8.43% | 13.84M +18.41% | -- -- | -- -- | -- -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 5.26M -- | -- -- | -- -- | -- -- | 18.86M +258.92% | -- -- | -- -- | -- -- | 37.53M +98.96% | -- -- | -- -- | -- -- | 49.94M +33.05% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Research and Development Expenses | 6.52M -- | 5.65M -- | 7.62M -- | 15.58M -- | 11.35M +73.92% | 13.42M +137.41% | 17.50M +129.65% | 25.94M +66.53% | 24.49M +115.87% | 33.13M +146.78% | 35.20M +101.18% | 37.28M +43.74% | 47.11M +92.36% | 47.26M +42.67% | 43.77M +24.34% | 46.81M +25.55% | 48.38M +2.69% | 50.98M +7.88% | 49.94M +14.10% | -- -- | -- -- | -- -- |
Operating Income | -7.37M -- | -6.69M -- | -8.97M -- | -17.60M -- | -14.06M -90.81% | -16.96M -153.72% | -23.50M -161.95% | -32.54M -84.89% | -31.93M -127.05% | -42.19M -148.71% | -43.86M -86.62% | -47.71M -46.62% | -58.26M -82.49% | -58.58M -38.85% | -52.33M -19.32% | -53.95M -13.07% | -56.84M +2.43% | -58.84M -0.44% | -56.91M -8.74% | -- -- | -- -- | -- -- |
Non-Operating Income (Loss) | 1.77M -- | -894.00K -- | -18.00K -- | -5.93M -- | 798.00K -54.81% | -36.00M -3926.96% | 753.00K +4283.33% | 1.20M +120.28% | 1.76M +120.43% | 1.25M +103.46% | -1.33M -276.63% | 6.68M +455.11% | 6.28M +257.25% | 4.78M +283.31% | 6.64M +599.47% | 5.63M -15.72% | 8.21M +30.71% | 9.10M +90.54% | 6.88M +3.58% | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -5.24M -- | -- -- | -- -- | -- -- | -33.39M -537.32% | -- -- | -- -- | -- -- | 1.49M +104.45% | -- -- | -- -- | -- -- | 165.00K -88.90% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | 1.77M -- | -894.00K -- | -18.00K -- | -854.00K -- | 798.00K -54.81% | -36.00M -3926.96% | 753.00K +4283.33% | 34.45M +4133.96% | 1.76M +120.43% | 1.25M +103.46% | -1.33M -276.63% | -1.68M -104.86% | 6.28M +257.25% | 4.78M +283.31% | 6.64M +599.47% | -17.70M -956.90% | 8.21M +30.71% | 9.10M +90.54% | 6.88M +3.58% | -- -- | -- -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -162.00K -- | -- -- | -- -- | -- -- | -142.00K +12.35% | -- -- | -- -- | -- -- | -6.87M -4735.92% | -- -- | -- -- | -- -- | -23.17M -237.35% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -5.60M -- | -7.58M -- | -8.99M -- | -23.53M -- | -13.26M -136.71% | -52.97M -598.75% | -22.75M -153.05% | -31.34M -33.17% | -30.17M -127.44% | -40.95M +22.69% | -45.19M -98.65% | -41.03M -30.94% | -51.98M -72.30% | -53.81M -31.41% | -45.69M -1.11% | -48.32M -17.76% | -48.63M +6.44% | -49.74M +7.56% | -50.03M -9.49% | -49.96M -3.40% | -30.95M +36.35% | -180.68M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 53.00K -- | -- -- | 176.00K -- | 67.00K -- | 32.00K -39.62% | 106.00K -- | 66.00K -62.50% | 104.00K +55.22% | 73.00K +128.13% | 79.00K -25.47% | 322.00K -- |
Current Income Tax | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 53.00K -- | -- -- | -- -- | -- -- | 275.00K +418.87% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -5.60M -- | -7.58M -- | -8.99M -- | -23.53M -- | -13.26M -136.71% | -52.97M -598.75% | -22.75M -153.05% | -31.34M -33.17% | -30.17M -127.44% | -40.95M +22.69% | -45.19M -98.65% | -41.09M -31.11% | -51.98M -72.30% | -53.98M -31.84% | -45.76M -1.26% | -48.35M -17.69% | -48.74M +6.23% | -49.80M +7.74% | -50.13M -9.56% | -50.03M -3.48% | -31.03M +36.32% | -181.01M -- |
Net Income Attributable to Owners of the Company | -5.60M -- | -7.58M -- | -8.99M -- | -23.53M -- | -13.26M -136.71% | -52.97M -598.75% | -22.75M -153.05% | -31.34M -33.17% | -30.17M -127.44% | -40.95M +22.69% | -45.19M -98.65% | -41.09M -31.11% | -51.98M -72.30% | -53.98M -31.84% | -45.76M -1.26% | -48.35M -17.69% | -48.74M +6.23% | -49.80M +7.74% | -50.13M -9.56% | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -5.60M -- | -7.58M -- | -8.99M -- | -23.53M -- | -13.26M -136.71% | -52.97M -598.75% | -22.75M -153.05% | -31.34M -33.17% | -30.17M -127.44% | -40.95M +22.69% | -45.19M -98.65% | -41.09M -31.11% | -51.98M -72.30% | -53.98M -31.84% | -45.76M -1.26% | -48.35M -17.69% | -48.74M +6.23% | -49.80M +7.74% | -50.13M -9.56% | -- -- | -- -- | -- -- |
Other Comprehensive Income | 11.00K -- | -19.00K -- | 13.00K -- | -6.00K -- | -1.00K -109.09% | -4.00K +78.95% | -5.00K -138.46% | -226.00K -3666.67% | -504.00K -50300.00% | -206.00K -5050.00% | 18.00K +460.00% | 226.00K +200.00% | 457.00K +190.67% | -517.00K -150.97% | 157.00K +772.22% | 869.00K +284.51% | -772.00K -268.93% | -115.00K +77.76% | 1.76M +1019.75% | -715.00K -182.28% | -35.00K +95.47% | 893.00K -- |
Total Comprehensive Income | -5.59M -- | -7.60M -- | -8.98M -- | -23.54M -- | -13.26M -137.20% | -52.97M -597.05% | -22.75M -153.47% | -31.56M -34.10% | -30.67M -131.23% | -41.15M +22.31% | -45.17M -98.52% | -40.86M -29.45% | -51.52M -67.98% | -54.50M -32.44% | -45.60M -0.95% | -47.48M -16.21% | -49.51M +3.90% | -49.92M +8.40% | -48.38M -6.08% | -50.75M -6.88% | -31.07M +37.25% | -180.11M -- |
Total Comprehensive Income Attributable to Owners of the Company | -5.59M -- | -7.60M -- | -8.98M -- | -23.54M -- | -13.26M -137.20% | -52.97M -597.05% | -22.75M -153.47% | -31.56M -34.10% | -30.67M -131.23% | -41.15M +22.31% | -45.17M -98.52% | -40.86M -29.45% | -51.52M -67.98% | -54.50M -32.44% | -45.60M -0.95% | -47.48M -16.21% | -49.51M +3.90% | -49.92M +8.40% | -48.38M -6.08% | -- -- | -- -- | -- -- |
Basic EPS | -2.92 -- | -3.41 -- | -3.81 -- | -- -- | -4.99 -70.89% | -6.66 -95.31% | -0.47 +87.66% | -0.65 -- | -0.62 +87.58% | -0.84 +87.39% | -0.79 -68.09% | -0.67 -3.08% | -0.84 -35.48% | -0.87 -3.57% | -0.72 +8.86% | -0.59 +11.94% | -0.59 +29.76% | -0.59 +32.18% | -0.59 +18.06% | -0.56 +5.08% | -0.35 +40.68% | -2.09 -- |
Diluted EPS | -2.92 -- | -3.41 -- | -3.81 -- | -- -- | -4.99 -70.89% | -6.66 -95.31% | -0.47 +87.66% | -- -- | -0.62 +87.58% | -0.84 +87.39% | -0.79 -68.09% | -- -- | -0.84 -35.48% | -0.87 -3.57% | -0.72 +8.86% | -- -- | -0.59 +29.76% | -0.59 +32.18% | -0.59 +18.06% | -- -- | -0.35 +40.68% | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
